Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Jan 27, 2017
Insider Transaction Report
Form 4
Preti Robert A
See Remarks
Transactions
- Tax Payment
Common Stock
2017-01-25$3.87/sh−272$1,053→ 42,870 total
Footnotes (1)
- [F1]Includes 17,518 shares of unvested restricted stock.